Effect of peroperative low-dose naloxone infusion on the development of remifentanil-induced shivering.Randomized double-blind study

Effect of peroperative low-dose naloxone infusion on the development of remifentanil-induced shivering.Randomized double-blind study - prevention of remifentanil-induced shivering by naloxone infusion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013549

Enrollment

200

Registered

2015-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients who receives remifentanil based anesthesia

Interventions

patients who receives remifentanil and saline infusion patients who receives remifentanil and naloxone infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients both sex who receives remifentanil based anesthesia for laparoscopic or open laparotomy

Exclusion criteria

Exclusion criteria: patients with febrile symptom, aptients who is obese.

Design outcomes

Primary

Measure	Time frame
presence of shivering within 2 hours after emergence from remifentanil based ansethesai	—

Countries

Japan

Contacts

Public ContactManzo Suzuki

Nippon Medical School Musashikosugi Hospital Anesthesiology

manzo@nms.ac.jp0447335181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026